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Abstract
Background: Diastolic dysfunction and elevated left ventricular (LV) filling pressure fol-
lowing acute myocardial infarction are associated with adverse outcomes. Although time to 
reperfusion is a powerful prognostic marker following acute myocardial infarction, little is 
known about its impact on diastolic function and LV filling pressure. We hypothesized that 
delayed time to reperfusion will be associated with worse diastolic function.
Methods: This study included 180 consecutive patients with first ST elevation myocardial in-
farction (STEMI) treated by primary percutaneous coronary intervention (PCI). They presen-
ted of chest pain within 24 h and underwent echocardiography within 3 days of primary PCI.
Results: Median time to reperfusion, defined as the time from symptom onset to reperfusion 
at the end of primary PCI, was 185 min (interquartile range 120–660). Patients with reperfu-
sion time > 185 min (n = 92) had a significantly higher E/septal e’ (13.3 ± 5.0 vs. 9.7 ± 2.3, 
p < 0.001) and E/lateral e’ (9.8 ± 3.5 vs. 7.8 ± 2.2, p < 0.001) ratios, and more advanced 
diastolic grade (p < 0.001) compared to those having early reperfusion (n = 88). There were 
no significant differences in LV ejection fraction and left atrial volume between the two groups. 
Time to reperfusion was an independent predictor of early E/average e’ ratio. The adverse ef-
fect of late reperfusion on diastolic dysfunction was more prominent in patients with anterior 
myocardial infarction.
Conclusions: Longer time to reperfusion is associated with early elevated LV diastolic pres-
sure in primary PCI-treated patients with STEMI. (Cardiol J 2014; 21, 4: 357–363)
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Introduction
Echocardiographic indices of elevated left 
ventricular (LV) filling pressures are associated 
with adverse remodeling, increased incidence of 
heart failure and worse survival following acute 
myocardial infarction (AMI) [1–4]. Doppler tissue 
imaging of mitral annulus velocity reflects the rate 
of change in LV long-axis dimension and volume, 
thus impaired relaxation results in a reduced early 
mitral annulus velocity (e’). Compared to other 
indicators of diastolic function, e’ velocity is re-
latively independent of preload, especially when 
the rate of myocardial relaxation is decreased 
[5–7]. The ratio of early transmitral flow velo-
city (E) to early diastolic septal or lateral mitral 
annulus velocity (E/e’) has been shown to be the 
most accurate noninvasive predictor of elevated 
LV filling pressure [5]. An elevated E/e’ ratio, 
especially one > 15, reportedly predicted poorer 
prognosis following MI [8, 9]. We evaluated the 
relation between time to reperfusion and the E/e’ 
ratio in patients presenting with first ST-segment 
elevation MI (STEMI), who underwent successful 
reperfusion with primary percutaneous coronary 
intervention (PPCI). We hypothesized that longer 
time to reperfusion would be associated with an 
elevated E/e’ ratio.
Methods
Our cohort included 265 consecutive patients 
with an acute STEMI, who were admitted to the 
cardiac intensive care unit (CICU) of the Tel-Aviv 
Sourasky Medical Center between May 2011 and 
January 2013, and underwent PPCI. The baseline 
demographic, clinical, echocardiographic and an-
giographic results were retrieved from medical 
files and the hospital database. Three patients who 
had severe valvular disease (1 with severe mitral 
regurgitation, and 2 with prosthetic valves), and 
7 with a previous history of ischemic heart disease 
were excluded. We excluded all patients older than 
75 years (n = 65) to avoid diastolic abnormalities that 
may be related to advanced age [10]. We excluded 
also 6 patients with severe hemodynamic instabili-
ty (e.g., cardiogenic shock at admission defined as 
persistent systolic blood pressure < 90 mm Hg and 
nonresponsive to fluid replacement, or the need for 
inotropes or intra-aortic balloon pumping to main-
tain blood pressure ≥ 90 mm Hg). Finally, 2 patients 
with no significant coronary lesions and 2 patients 
with failed reperfusion (defined as TIMI flow < 3 
at the end of PPCI) were also excluded because of 
inability to accurately measure “reperfusion time”.
The diagnosis of STEMI was based on typical 
history of chest pain, diagnostic electrocardiogra-
phic changes, and serial elevation of serum cardiac 
biomarkers in all patients [11]. The electrocardio-
graphic criterion for the diagnosis of STEMI was 
an ST-segment elevation of ≥ 1 mm in > 2 adjacent 
leads. The patients were treated according to the 
discretion of the senior attending physician in the 
CICU. PPCI was performed in all patients irrespec-
tive of duration of symptoms. Angiographic corona-
ry artery stenosis was defined as luminal diameter 
narrowing ≥ 70%. Coronary artery blood flow was 
defined according to standardized thrombolysis in 
MI (TIMI) grades 0–3 [12]. A culprit artery was 
defined as one with an identifiable thrombotic 
lesion on an angiogram corresponding to electro-
cardiographic changes. Successful reperfusion was 
defined as < 30% residual stenosis and TIMI grade 
3 flow. Time to reperfusion was defined as the time 
from symptom onset (usually chest pain or discom-
fort) recorded upon admission to the restoration of 
TIMI grade 3 flow in the infarct artery, as reported 
in the catheterization laboratory report.
All patients underwent a screening echocar-
diographic examination within 2–72 h from PPCI. 
Echocardiography was performed by Philips IE-33, 
GE and Vivid 3 models equipped with S5-1 transdu-
cers (Philips Healthcare, Andover, MA, USA). LV 
diameters and interventricular septal and posterior 
walls widths were measured from the parasternal 
short axis by means of a two-dimensional (2D), or 
a 2D-guided M-mode echocardiogram of the LV at 
the papillary muscle level, using the parasternal 
short-axis view [13]. LV ejection fraction (LVEF) 
was calculated by the Quinones method [13]. The 
16-segment model was used for scoring the seve-
rity of segmental wall motion abnormalities accor-
ding to the American Society of Echocardiography 
[14]. Early transmitral flow velocity (E) and early 
diastolic mitral annular velocity (e’) were measured 
in the apical 4-chamber view to provide an estimate 
of LV diastolic function [15]. The e’ was measured 
from septal and lateral annulus. The ratio of peak E 
to peak e’ (septal, lateral and average) was calcula-
ted (mitral E/e’ ratio) from the average of at least 
3 cardiac cycles. The deceleration time of the E-wave 
was also measured. Left atrial (LA) volume was cal-
culated using the biplane area length method at end 
systole [16]. The cardiac output was calculated as 
the product of aortic stroke volume and heart rate, 
as demonstrated on pulse wave Doppler. Valvular 
regurgitation was qualitatively assessed using 
color Doppler according to the guidelines of the 
American Society of Echocardiography (normal/ 
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/trivial = 1, mild = 2, moderate = 3, severe = 4) 
[17]. Diastolic function was assessed by integrating 
measurements of the mitral inflow, LA volume and 
Doppler tissue imaging of the mitral annulus, based 
on recent guidelines [15] and classified into four 
categories: normal diastolic function = 0, impaired 
relaxation = 1, pseudo-normal = 2 and restrictive 
pattern = 3 based on recent guidelines [15]. Right 
atrial (RA) pressure was estimated by the inferior 
vena cava (IVC) diameter as well as its response 
to inspiration, as previously described [18]. Brie-
fly, expiratory and inspiratory IVC diameters and 
percent collapse were measured in subcostal views 
within 2 cm of the RA. IVC diameter < 2.1 cm that 
collapsed > 50% with a sniff suggested normal 
RA pressure (assigned as 5 mm Hg), whereas an 
IVC diameter > 2.1 cm that collapsed < 50% with 
a sniff suggested high RA pressure (15 mm Hg). 
In patients with IVC diameter < 2.1 cm and no 
collapse (< 20%) with a sniff, RA pressure was 
upgraded to 20 mm Hg. In indeterminate cases 
in which the IVC diameter and collapse did not fit 
this paradigm, secondary indices of elevated RA 
pressure were integrated. If uncertainty remained, 
RA pressure was left as intermediate value of 
10 mm Hg. Peak systolic pulmonary artery pres-
sure was estimated using the modified Bernoulli 
formula (4 × TRVmax2) + RAP, where TRVmax is 
the peak systolic tricuspid regurgitation velocity at 
end expiration, and RAP is the RA pressure.
Troponin I assays were performed at admis-
sion and then at 12, 24 and 48 h to determine 
enzymatic infarct size. Similarly, creatine kinase 
levels were measured serially at admission and 
then every 6 h until peak levels were reached.
The study was approved by the local com-
mittee and all patients gave their informed 
consent.
Statistical analysis
All data were summarized and displayed as 
mean (± standard deviation) for continuous va-
riables and as number (percentage) of patients in 
each group for categorical variables. The p values 
for the χ2 test were calculated with Fisher’s exact 
test. The p value for the t-test is reported according 
to Levene’s test for equality of variance. Linear 
regression models were performed at the ENTER 
mode where the dependant variable was defined 
as average E/e’ and adjusted to age, gender, LVEF, 
history of diabetes, hypertension, peak creatine 
phosphokinase, and peak troponin and ischemia du-
ration. All the analyses were considered significant 
at a 2-tailed p value < 0.05. The SPSS statistical 
package was used to perform all statistical evalu-
ations (SSPS, Chicago, IL).
Results
A total number of 180 consecutive patients 
(mean age 56 ± 9 years, range 33–75, 82% males) 
met the inclusion criteria of this study and their 
data were included in the analyses. The median 
total time to reperfusion was 185 min (interquartile 
range 120–660). Eighty-eight (49%) patients had 
time to reperfusion £ 185 min and 92 (51%) had 
time to reperfusion > 185 min. Baseline echocar-
diograms were obtained 1.6 ± 1.4 days following 
admission. Table 1 presents clinical, laboratory 
and angiographic data of patients with time to 
reperfusion ≤ 185 min and >185 min. There were 
no significant differences between the groups in 
these parameters other than a greater prevalence 
of women, and higher C-reactive protein levels 
in the group with time to reperfusion > 185 min. 
Table 2 displays the admission echocardiogra-
phic data of the two groups. Patients with time to 
reperfusion > 185 min had a significantly higher 
mean mitral inflow E wave velocity (78 ± 19 vs. 
68 ± 16 cm/s, p = 0.001), a lower septal e’ ve-
locity (6.3 ± 1.8 vs. 7.3 ± 1.8 cm/s, p = 0.001), 
a higher E/septal e’ ratio (13.3 ± 5.0 vs. 9.7 ± 2.3, 
p < 0.001), E/lateral e’ ratio (9.8 ± 3.5 vs. 7.8 ± 
± 2.2, p < 0.001), and E/average e’ ratio (11 ± 3.6 
vs. 8.6 ± 1.9, p < 0.001) than patients with time 
to reperfusion £ 185 min. Distribution of diasto- 
lic function was significantly different between 
the groups, with 43% of the early reperfusion 
patients having normal diastolic function and 
12% of them having grade 2 diastolic dysfunction 
(pseudo-normal pattern), compared to only 20% 
normal and 32% pseudo-normal diastolic function, 
in the late time to reperfusion group (p < 0.001), 
respectively. There were no significant changes in 
LVEF, cardiac output, or LA volume between the 
groups. The changes in diastolic parameters were 
more prominent among patients having anterior 
MI (n = 87) and confined to septal e’, E/septal e’ 
and E/average e’ in patients with non-anterior MI 
(Table 3). In sub-group analysis performed in 114 pa- 
tients, in whom echocardiography was performed 
within 24 h of PPCI, diastolic function was worse 
in patients with later reperfusion (Table 4). Linear 
logistic regression model incorporating predictors 
of average E/e’ ratios, such as age, gender, LVEF, 
diabetes, hypertension, peak creatine phospho-
kinase, and peak troponin showed that time to 
reperfusion, hypertension and gender were the 
only independent predictors of E/e’ ratio (Table 5).
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Discussion
The principal finding of the current study is 
that longer time to reperfusion in patients with 
STEMI is associated with immediate worsening of 
diastolic function and elevated LV filling pressure, 
independent of LV systolic function or cardiac 
output. The elevated LV filling pressure combined 
with preserved cardiac output suggests that even 
a small delay in reperfusion (> 3 h) leads to changes 
in the Frank-Starling curves of the ischemic/stun-
ned heart, resulting in maintained cardiac output 
and ejection fraction at the price of increasing 
filling pressures.
Time to reperfusion is a known powerful 
prognostic marker in AMI patients undergoing 
reperfusion [9, 19, 20] and major consideration 
is given to minimizing ischemic duration in order 
to improve survival following AMI [21]. Time to 
reperfusion is known to determine infarct size [22, 
23] and systolic function [23] but there are only 
a few studies regarding its effect on diastolic fun-
ction and filling pressure [24]. Prasad et al. [24] 
demonstrated that delayed reperfusion after 
STEMI was associated with increased prevalence 
of severe LV diastolic dysfunction and lower LVEF. 
However, in that report, patients with a restrictive 
pattern also had worse systolic dysfunction and 
significantly higher LA volume, suggesting that 
the reported restrictive physiologic changes may 
have been related to systolic dysfunction or to 
chronic diastolic dysfunction rather than to the 
acute event [25, 26].
Unlike previous studies, where diastolic dys-
function and evidence of elevated filling pressure 
(elevated E/e’ ratio) following AMI were associated 
with reduced LV systolic function [8, 24] no such 
relation was found among our patients, possibly 
because all patients had undergone PPCI, thus 
systolic dysfunction was rare in both groups. 
The elevation in E and E/e’ ratio in patients with 
longer ischemia duration was not associated with 
any difference in the ratio between early (E) and 
late (atrial, A) ventricular filling velocity (the E/A 
ratio) because the distribution of diastolic function 
was mostly normal in the early reperfusion group, 
as opposed to largely pseudo-normal in the late 
reperfusion group. The differences in systolic 
pulmonary artery pressure between the early and 
late reperfusion groups did not reach statistical 
Table 1. Baseline characteristics of 180 consecutive patients presenting with first-ever ST elevation 
myocardial infarction.
Variable Time to reperfusion P*
£ 185 min (n = 88) > 185 min (n = 92)
Age [years] 56 ± 9 58 ± 9 NS
Men 81 (54%) 68 (46%) 0.001
Diabetes mellitus 9 (10%) 16 (17%) NS
Dyslipidemia 38 (43%) 34 (37%) NS
Hypertension 27 (31%) 34 (37%) NS
Smoker 55 (62%) 58 (63%) NS
Family history of coronary artery disease 20 (23%) 22 (24%) NS
Number of narrowed coronary arteries:
1 49 (56%) 36 (39%) NS
2 26 (30%) 31 (34%) NS
3 13 (14%) 25 (27%) NS
Proximal infarct related artery narrowing 46 (52%) 50 (54%) NS
Pre-angioplasty TIMI flow 0 54 (62%) 60 (65%) NS
Anterior infarct location 44 (50%) 43 (47%) NS
Time to reperfusion [min] 134 ± 28 643 ± 500 < 0.001
Time to echocardiogram [days] 1.65 ± 1.5 1.6±1.3 NS
Peak creatine kinase [IU/L] 1453 ± 1538 1548 ± 1668 NS
Peak troponin [ng/mL] 48 ± 61 48 ± 61 NS
C reactive protein [mg/L] 6.1 ± 10.6 19.4 ± 30.8 < 0.001
*The p values for the c2 test were calculated with the Fisher’s exact test. The p value for the t-test is reported following Levene’s test for  
equality of variance; non-significant (NS) indicates 2-tailed non-significance (p > 0.05); TIMI — thrombolysis in myocardial infarction
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Table 2. Echocardiographic data of 180 consecutive patients presenting with first-ever ST elevation 
myocardial infarction.
Variable Time to reperfusion P*
£ 185 min (n = 88) > 185 min (n = 92)
Biplane left ventricular ejection fraction 48 ± 8 47 ± 8 NS
Heart rate [bpmin] 72 ± 10 76 ± 12 NS
Systolic blood pressure [mm Hg] 136 ± 20 136 ± 17 NS
Diastolic blood pressure [mm Hg] 81 ± 13 81 ± 12 NS
Cardiac output [L/min] 5.1 ± 1.0 5.3 ±1.2 NS
Diastolic grade [%] Normal (43); Grade I (38) 
Grade II (12); Grade III (7)
Normal (20); Grade I (42)  
Grade II (32); Grade III (7)
< 0.001
Left atrial volume [mL] 62 ± 16 61 ± 17 NS
Left atrial volume index [mL/m2] 32 ± 8 32 ± 9 NS
Mitral inflow E wave [cm/s] 68 ± 16 77 ± 19 0.001
Mitral inflow E/A ratio 1.17 ± 0.45 1.15 ± 0.44 NS
Septal e’ velocity [cm/s] 7.3 ± 1.8 6.3 ± 1.8 < 0.001
E wave velocity/septal e’ 9.7 ± 2.3 13.3 ± 5.0 < 0.001
Lateral e’ velocity [cm/s] 8.21 ± 2.3 8.6 ± 2.8 NS
E wave velocity/lateral e’ 9.3 ± 2.5 9.8 ± 3.5 < 0.001
Average e’ velocity [cm/s] 7.8 ± 2.2 7.31 ±1.8 < 0.001
E wave velocity/average e’ 8.6 ± 1.9 11 ± 3.6 < 0.001
Mitral E wave deceleration time [ms] 180 ± 43 178 ± 45 NS
LV end diastolic dimension [mm] 48 ± 7.8 47.1 ± 11.7 NS
LV end systolic dimension [mm] 30.7 ± 6.8 30.8 ± 9.4 NS
Septal thickness [mm] 10.9 ± 1.7 12.6 ± 1.5 NS
Posterior wall thickness [mm] 10.2 ± 2.4 9.7 ± 2.7 NS
Systolic pulmonary artery pressure [mm Hg] 28 ± 7 31 ± 9 NS
Right atrial pressure [mm Hg] 5 ± 2 6 ± 3 NS
*The p values for the c2 test were calculated with the Fisher’s exact test. The p value for the t-test is reported following Levene’s test for  
equality of variance; non-significant (NS) indicates 2-tailed non-significance (p > 0.05).
Table 3. Echocardiographic data according infarct location.
Variable Anterior  
infarction
Non anterior  
infarction
Time to reperfusion P Time to reperfusion P
£ 185 min
(n = 44)
> 185 min  
(n = 43)
£ 185 min  
(n = 44)
> 185 min  
(n = 49)
LV ejection fraction 45 ± 8 43 ± 6 NS 51 ± 7 50 ± 8 NS
Cardiac output [L/min] 4.6 ± 1 5.1 ± 1 NS 5.6 ± 1 5.5 ± 1 NS
Left atrial volume [mL3] 64 ± 16 61 ± 17 NS 60 ± 16 61 ± 17 NS
E wave velocity [cm/s] 66 ± 15 73 ± 19 NS 70 ± 17 81 ± 18 0.003
E/A ratio 1.2 ± 0.4 1.1 ± 0.4 NS 1.2 ± 0.5 1.2 ± 0.4 NS
e’ septal [cm/s] 6.7 ± 1.5 5.7 ± 1.4 0.003 7.8 ± 2.0 6.7 ± 2.0 0.01
E/e’ septal 10.1 ± 2.2 13.4 ± 4.8 < 0.001 9.3 ± 2.3 13.2 ± 5.2 < 0.001
e’ lateral [cm/s] 9.0 ± 2.2 8.1 ± 2.5 0.01 9.5 ± 2.8 8.9 ± 3.0 NS
E/e’ lateral 7.7 ± 1.9 9.9 ± 4.0 0.001 7.9 ± 2.4 9.7 ± 2.1 NS
Average e’ [cm/s] 7.5 ± 2.3 6.2 ±2.2 0.008 8.0 ± 2.7 7.1 ± 2.7 NS
E/e’ average 8.7 ± 1.7 11.1 ± 2.9 0.001 8.5 ± 2.1 10.8 ± 3.1 < 0.001
Mitral E wave deceleration time [ms] 167 ± 36 175 ± 39 NS 192 ± 45 180 ± 50 NS
LVEDD [mm] 48 ± 8 47 ± 12 NS 47 ± 8 47 ± 11 NS
LVESD [mm] 31 ± 7 31 ± 10 NS 30 ± 6 31 ± 9 NS
SPAP [mm Hg] 27 ± 6 32 ± 8 0.004 29 ± 7 30 ± 10 NS
Right atrial pressure [mm Hg] 5 ± 2 7 ± 4 0.03 5 ± 2 5 ± 2 NS
LV — left ventricular; LVEDD — LV end-diastolic dimension; LVESD — LV end-systolic dimension; SPAP — systolic pulmonary artery pressure
www.cardiologyjournal.org 361
Yacov Shacham et al., Ischemia duration following STEMI and E/e’ ratio
significance. Pulmonary systolic pressure is a less 
sensitive marker for elevated LV filling pressures 
than E/e’, thus the lack of difference may be rela-
ted to the small number of patients and the lack of 
power to detect them.
Limitations of the study
The present study has some limitations that 
warrant mention. Echocardiographic findings with-
in 1–3 days of AMI may represent various states 
of LV loading due to heart failure, fluid management 
and medications admitted upon admission, such as 
nitrates, beta-blockers and angiotensin converting 
enzyme inhibitors, which may influence preload 
and afterload, thus possibly affecting mitral inflow 
measurements. Importantly, a sub-analysis of pa-
tients in whom echocardiography was performed 
within 24 h of PPCI, demonstrated similar results 
to that of the general cohort suggesting that early 
reperfusion and not other later factors is the main 
determinant of diastolic dysfunction post MI. 
In addition, age-related changes [10] as well as 
baseline diabetes and hypertension may result in 
a background level of diastolic dysfunction. Bearing 
these possibilities in mind, we excluded patients 
older than 75 years, whereby the mean age of our 
Table 4. Echocardiographic data of 114 patients with echocardiography performed within 24 h of pri-
mary percutaneous coronary intervention.
Variable Time to reperfusion P*
£ 185 min (n = 54) > 185 min (n = 60)
Biplane LV ejection fraction 47 ± 7 47 ± 8 NS
Heart rate [bpm] 72 ± 10 75 ± 11 NS
Systolic blood pressure [mm Hg] 137 ± 20 139 ± 18 NS
Diastolic blood pressure [mm Hg] 80 ± 12 82 ± 14 NS
Cardiac output [L/min] 5.1 ± 1.3 5.4 ± 1.1 NS
Left atrial volume [mL] 64 ± 16 58 ± 15 NS
Left atrial volume index [mL/m2] 33 ± 8 30 ± 8 NS
Mitral inflow E wave [cm/s] 64 ± 16 78 ± 20 0.003
Mitral inflow E/A ratio 1.15 ± 0.46 1.15 ± 0.40 NS
Septal e’ velocity [cm/s] 7.3 ± 1.9 6.4 ± 1.7 0.01
E wave velocity/septal e’ 9.6 ± 2.0 13.1 ± 5.2 < 0.001
Lateral e’ velocity [cm/s] 9.3 ± 2.6 9.1± 2.9 NS
E wave velocity/lateral e’ 7.8 ± 2.2 9.3 ± 3.1 0.01
Average e’ velocity [cm/s] 7.8 ± 2.6 6.9 ± 27 0.08
E wave velocity/average e’ 8.6 ± 1.7 10.4 ± 3.0 < 0.001
Mitral E wave deceleration time [ms] 182± 44 175 ± 46 NS
LV end diastolic dimension [mm] 47 ± 7 46 ± 12 NS
LV end systolic dimension [mm] 31± 6 30 ± 10 NS
Septal thickness [mm] 10.9 ± 1.7 12.6 ± 1.5 NS
Posterior wall thickness [mm] 10.9 ± 1.6 9.8 ± 3.0 NS
Systolic pulmonary artery pressure [mm Hg] 28 ± 7 31 ± 9 NS
Right atrial pressure [mm Hg] 5 ± 2 6 ± 4 NS
*The p values for the c2 test were calculated with the Fisher’s exact test. The p value for the t-test is reported following Levene’s test for  
equality of variance; non-significant (NS) indicates 2-tailed non-significance (p > 0.05); LV — left ventricular
Table 5. Linear logistic regression model.
Correlates E/e’ ratio
Beta P
Age 0.119 0.123
Gender 0.169 0.024
Diabetes 0.129 0.095
Hypertension 0.179 0.02
Peak creatine phosphokinase 0.019 0.863
Peak troponin 0.118 0.259
Left ventricular ejection fraction 0.149 0.083
Time to reperfusion 0.166 0.023
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cohort was significantly lower than the mean ages 
of patients in previous trials that assessed E/e’ 
in AMI [8, 9, 24]. No information was present 
regarding correlation of E/e’ with LV end diastolic 
pressure, measured in cardiac catheterization, as 
this is not routinely performed during PPCI in our 
institute. We also had no information on long-term 
prognosis of our study participants.
Conclusions
While PPCI within 24 h of ischemia onset pre-
vents significant LV systolic dysfunction in STEMI 
patients, even small delays in reperfusion may 
result in acute changes in the LV hemodynamics 
known to be associated with adverse outcomes.
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